I'm in it because of the certainty in the CAH cost of revenue ratios, the year old insider trading reporting requirements that few OTC traders seem to know or understand, and six earnings reports in a row showing a company turnaround. I own no other OTC stock and haven't seen one for a good while that I would touch other than RNVA. To each his own.
News 
Market Data 
Discover 
AI
